Focused Wealth Management, Inc Curis Inc Transaction History

Focused Wealth Management, Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$0.57 - $0.99 $10,687 - $18,562	18,750 Added 3.75%	519,199 $430,000
Q1 2023 Apr 13, 2023	BUY	$0.51 - $0.78 $16,447 - $25,155	32,250 Added 6.89%	500,449 $300,000
Q4 2022 Jan 13, 2023	BUY	$0.47 - $17.22 $23,500 - $861,000	50,000 Added 11.96%	468,199 $0
Q3 2022 Oct 20, 2022	BUY	$0.74 - $15.01 $1,642 - $33,322	2,220 Added 0.53%	418,199 $293,000
Q2 2022 Aug 04, 2022	BUY	$0.71 - $2.43 $205,343 - $702,794	289,216 Added 228.15%	415,979 $410,000
Q4 2021 Jan 31, 2022	BUY	$4.45 - $8.09 $179,112 - $325,622	40,250 Added 46.52%	126,763 $603,000
Q3 2021 Oct 12, 2021	BUY	$6.94 - $8.85 $54,499 - $69,499	7,853 Added 9.98%	86,513 $677,000
Q2 2021 Jul 15, 2021	BUY	$7.45 - $16.27 $58,504 - $127,768	7,853 Added 11.09%	78,660 $635,000
Q4 2020 Feb 03, 2021	SELL	$1.08 - $8.2 $61,767 - $468,974	-57,192 Reduced 44.68%	70,807 $580,000
Q3 2020 Oct 19, 2020	BUY	$0.95 - $1.42 $63,271 - $94,574	66,602 Added 108.48%	127,999 $150,000
Q4 2019 Jan 21, 2020	BUY	$1.36 - $2.44 $32,640 - $58,560	24,000 Added 64.18%	61,397 $104,000
Q3 2018 Nov 13, 2018	BUY	$1.38 - $1.94 $690 - $970	500 Added 1.36%	37,397 $67,000
Q2 2018 Aug 15, 2018	BUY	$1.73 - $3.35 $63,831 - $123,604	36,897 New	36,897 $64,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Focused Wealth Management, Inc with notifications on news.